Status:
COMPLETED
Norwegian Adenomyosis Study I
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Helse Sor-Ost
Conditions:
Adenomyosis
Eligibility:
FEMALE
25-50 years
Brief Summary
Adenomyosis is characterized by the appearance of endometrial cells in the muscular layer of the uterus. It affects about 15-20% of the female population. The symptoms of adenomyosis are heavy menstr...
Detailed Description
Diagnosis of Adenomyosis with 3D and 2D transvaginal ultrasound. Prospective study of a consecutive series of 101 patients that are scheduled for hysterectomy and suffer from bleeding disorders, chron...
Eligibility Criteria
Inclusion
- Premenopausal women aged 30 - 50 years old
- scheduled for vaginal, abdominal or laparoscopic total hysterectomy
- one or more of the following clinical symptoms: bleeding disorders (menorrhagia, irregular bleeding, hypermenorrhoea), chronic pelvic pain, dysmenorrhoea, or dyspareunia
- junction zone definable
Exclusion
- postmenopausal women,
- pregnancy
- gynecological cancer
- GnRH analog therapy or systemic hormone therapy in the last three months prior to hysterectomy
- junctional zone not identifiable
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02201719
Start Date
July 1 2014
End Date
January 1 2017
Last Update
April 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gynecology, Oslo University Hospital Ullevål
Oslo, Oslo County, Norway, 0382